<DOC>
	<DOCNO>NCT00922181</DOCNO>
	<brief_summary>Microwave ablation ( MWA ) recent development field local ablative therapy . The aim study evaluate variability reproducibility single-probe MWA versus radiofrequency ablation ( RFA ) metastatic liver tumours small 3 cm patient without underlie liver disease .</brief_summary>
	<brief_title>Single-probe Microwave Ablation ( MWA ) Metastatic Liver Cancer</brief_title>
	<detailed_description />
	<mesh_term>Liver Neoplasms</mesh_term>
	<mesh_term>Liver Extracts</mesh_term>
	<criteria>Unresectable metastatic liver cancer No invasion major biliary structure No invasion major vascular structure ASA score &lt; 4 WHO score 01 Preoperative chemotherapy allow Resectable liver metastases Life expectancy le 3 month Patients cardiac pacemaker , cerebral aneurysm clip , implant electronic instrument metal material Coagulopathy platelet count le 50000 Active infectious disease Age 18 year Pregnancy breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>November 2009</verification_date>
	<keyword>malignancy</keyword>
	<keyword>liver</keyword>
	<keyword>microwave</keyword>
	<keyword>surgery</keyword>
</DOC>